Hojjat Ahmadzadehfar

German Multicenter Study Investigating¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil et al. · Journal of Nuclear Medicine · 2016 · 832 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation

Bruno Sangro, L Carpanese, Roberto Cianni et al. · Hepatology · 2011 · 654 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study

Hojjat Ahmadzadehfar, Kambiz Rahbar, Stefan Kürpig et al. · EJNMMI Research · 2015 · 293 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer

Hojjat Ahmadzadehfar, Elisabeth Eppard, Stefan Kürpig et al. · Oncotarget · 2016 · 285 citations · Full text

Medicine, Oncology, Pharmacology +17

Response and Tolerability of a Single Dose of¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis

Kambiz Rahbar, Matthias Schmidt, Alexander Heinzel et al. · Journal of Nuclear Medicine · 2016 · 205 citations · Full text

Medicine, Nuclear Medicine, Oncology +17